PAREXEL Early Phase — Glendale, California

PAREXEL Early Phase is a clinical research site located in Glendale, California, United States 91206.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

PAREXEL Early Phase has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: CoMentis.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PAREXEL Early Phase?

PAREXEL Early Phase has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PAREXEL Early Phase conducted?

PAREXEL Early Phase has 1 clinical trials on record. Their work covers Schizophrenia.

Is PAREXEL Early Phase accredited by Crixeo Health?

PAREXEL Early Phase has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PAREXEL Early Phase?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.